Motility inhibition of the gastrointestinal tract

Indication for Glucagon

Population group: Suitable for both men and women, only adults (18 years old or older)
Therapeutic intent: Diagnostic

Glucagon is indicated for motility inhibition in examinations of the gastrointestinal tract.

For this indication, competent medicine agencies globally authorize below treatments:

1-2 mg once

For: Adults (18-64) Elders (65+)

Route of admnistration

Intramuscular

Defined daily dose

1 - 2 mg

Dosage regimen

From 1 To 2 mg once every day

Detailed description

The diagnostic dose for relaxation of the stomach, duodenal bulb, duodenum and small bowel is 1 mg given intramuscularly; the dose to relax the colon is 1–2 mg intramuscularly.

Dosage considerations

The onset of action after an intramuscular injection of 1–2 mg occurs after 5–15 minutes and lasts approximately 10–40 minutes.

After end of the diagnostic procedure oral carbohydrate should be given, if this is compatible with the diagnostic procedure applied.

0.2-0.75 mg once

For: Adults (18-64) Elders (65+)

Route of admnistration

Intravenous

Defined daily dose

0.2 - 0.75 mg

Dosage regimen

From 0.2 To 0.75 mg once every day

Detailed description

The diagnostic dose for relaxation of the stomach, duodenal bulb, duodenum and small bowel is 0.2–0.5 mg given as intravenous injection; the dose to relax the colon is 0.5–0.75 mg intravenously.

Dosage considerations

Onset of action after an intravenous injection of 0.2–0.5 mg occurs within one minute and the duration of effect is between 5 and 20 minutes.

After end of the diagnostic procedure oral carbohydrate should be given, if this is compatible with the diagnostic procedure applied.

Active ingredient

Glucagon is a hyperglycaemic agent that mobilises hepatic glycogen, which is released into the blood as glucose. Glucagon inhibits the tone and motility of the smooth muscle in the gastrointestinal tract.

Read more about Glucagon

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner